Dog Dementia Statistics 2026: Prevalence, Diagnosis Rates, and Risk Factors
How common is dog dementia, how often is it actually diagnosed, and what raises the risk? This page collects the published numbers in one place – every statistic linked to the primary study that produced it, with the study design stated so you know what each number can and cannot tell you. It covers epidemiology only; treatment evidence is reviewed separately in our supplements guide and medication guide.
Quick answer
In the benchmark 2010 survey, 14.2% of dogs over age eight were provisionally classified with canine cognitive dysfunction (CCD) by a validated owner questionnaire, while only 1.9% of dogs had a reported veterinary diagnosis – a gap the study’s authors call underdiagnosis. Risk climbs steeply with age: a 15,019-dog Dog Aging Project cohort measured 52% higher adjusted odds of CCD with each additional year. Published estimates vary widely because studies measure different things in different age groups – the sections below give each number with its source and its limits.
Key statistics at a glance
- In a 2010 survey of older companion dogs, 14.2% of dogs over age eight were provisionally classified with canine cognitive dysfunction (CCD) based on a validated owner questionnaire. Salvin 2010 ¶
- In the same surveyed population, only 1.9% of dogs had a reported veterinary diagnosis of CCD – a large gap between estimated prevalence and recorded diagnosis. Salvin 2010 ¶
- In a 15,019-dog Dog Aging Project cohort, the adjusted odds of CCD were 52% higher with each additional year of age. Yarborough 2022 ¶
- Age-band data from a 180-dog cohort study: impairment in at least one behavior category was reported in 28% of dogs aged 11-12 (n=80) and 68% of dogs aged 15-16 (n=34). Neilson 2001 ¶
- Dogs reported as not active had 6.47 times the odds of CCD versus very active dogs of the same age and health status – an association whose direction (cause, consequence, or both) the study design cannot determine. Yarborough 2022 ¶
- In a 2025 survey of US veterinarians (n=318), 97.2% had diagnosed CCD in their career, while about 80% rarely or never refer suspected cases to a specialist. Simon 2025 ¶
How common is dog dementia?
14.2% of dogs over age eight were provisionally classified with CCD in the benchmark 2010 cross-sectional survey (mean age 11.7 years, range 8 to 19.8), using a validated owner-report instrument rather than a clinical examination. Estimated prevalence rose steeply with age within the sample (Salvin et al., The Veterinary Journal, 2010).
How big is the diagnosis gap?
The same survey reported two population rates side by side: an estimated 14.2% of dogs met the questionnaire’s provisional CCD classification, while 1.9% of dogs had a reported veterinary diagnosis of CCD. The study’s own title calls this “under diagnosis”: most dogs whose owners report CCD-consistent signs carry no diagnosis, usually because the early signs read as normal aging and rarely come up in a short appointment. The two figures are separate population estimates measured differently – a questionnaire classification and a reported diagnosis – so the honest statement is the gap itself, not a precise fraction of missed cases (Salvin et al., 2010).
How does risk change with age?
Two independent datasets, twenty years apart, agree that age is the dominant risk factor. In the Dog Aging Project cohort of 15,019 companion dogs, the adjusted odds of CCD rose 52% with each additional year of age when controlling for other characteristics (Yarborough et al., Scientific Reports, 2022). The age-band figures below come from Neilson’s 180-dog cohort study, in which “impairment” means owner-reported dysfunction in a behavior category, not a clinical diagnosis:
Dogs with age-related behavioral impairment, by age band
Data: Neilson et al., JAVMA 2001; owner-reported behavior categories; denominators n=80 (age 11-12) and n=34 (age 15-16). Chart: Dr. Fossum’s Pet Care – free to reuse with a link to this page.
Neither Neilson 2001 nor Salvin 2010 detected a statistically significant association between body weight or breed size and these signs – which is evidence of no detected effect, not proof that size plays no role.
What is associated with higher risk?
Dogs reported as not active had 6.47 times the odds of CCD versus very active dogs, among dogs of the same age, health status, breed type, and sterilization status. The same analysis found higher odds in dogs with a history of neurological, eye, or ear disorders. This is an observational association: the study cannot determine whether low activity contributes to decline, results from it, or both. It does not establish that exercise prevents CCD (Dog Aging Project – Yarborough et al., 2022).
Why do published estimates differ so much?
Readers will meet prevalence figures ranging from a few percent to two-thirds of senior dogs. The variation is real and explainable, and comparing numbers without these distinctions produces wrong conclusions:
| Study | Population | What was measured | Headline figure |
|---|---|---|---|
| Salvin 2010 | Community dogs over 8 | Validated owner questionnaire, provisional CCD classification | 14.2% |
| Neilson 2001 | 180 dogs aged 11-16, screened to exclude other organ disease | Owner interview; impairment = 2+ signs within a behavior category | 28% to 68% by age band |
| Yarborough 2022 | 15,019 Dog Aging Project dogs, all ages | CCD rating scale cutoff; odds modeling across ages | +52% odds per year |
Three lessons carry across the whole literature. First, an owner-questionnaire classification is not a clinical diagnosis – it is a screening signal. Second, age windows drive headline numbers: a study of 15-year-olds will always report more impairment than a study of 9-year-olds. Third, owner-reported scores can move for reasons other than the disease: a 2025 clinical-trial cohort found improvement on one owner-reported cognitive scale even among dogs receiving placebo, a caution that applies to any uncontrolled before-and-after result in this field (Simon et al., 2025).
How do US veterinarians handle it?
A 2025 survey of 318 US veterinarians found: 97.2% had diagnosed CCD in their career; about 80% rarely or never refer suspected cases to a specialist; selegiline – the one medication FDA-approved for control of clinical signs associated with CCD (NADA 141-080) – was the single most-selected product when respondents were asked which management option they consider most effective, chosen by 91 of 312 answering that question (about 30%, a measure of practitioner opinion, not of treatment response). Cost was named as a barrier to recommending management by 95 of 316 respondents, and respondents cited absent guidelines and knowledge gaps as obstacles (Simon, Gruen, Olby, 2025).
That guidelines gap is closing: the CCDS Working Group published proposed standardized diagnostic and monitoring guidance in JAVMA – online December 24, 2025, print April 2026 (Olby et al.).
What is it like for the humans?
Caregiver burden in CCD is now a studied subject of its own. A 2026 cross-sectional survey of 516 dog owners in Slovenia, spanning comparison groups that included cognitive dysfunction, cancer, and general age-related decline, documented measurable psychological burden among caregivers of affected dogs (Pavlin et al., The Veterinary Journal, 2026). The night-time signs – sleep disruption and anxiety – are consistently described as the hardest part to live with, which matches what long-term follow-up identified as dominant clinical signs. If that is your house right now, our sundowning guide and caregiver guide were written for it.
Does dementia shorten a dog’s life?
One observational study followed 94 older dogs for several years (enrolled 2008-2009, follow-up 2012) and did not detect a negative association between CCD and survival; the authors concluded that supported dogs “seem to have a good chance of living a full lifespan.” A single observational cohort cannot determine any individual dog’s prognosis, and quality of life – especially at night – remains the practical battleground. The same study identified four dominant clinical signs (day sleeping with night restlessness, decreased interaction, disorientation at home, anxiety) and observed borderline cases progressing to CCD over time, evidence that a prodromal stage exists (Fast et al., J Vet Intern Med, 2013).
Where treatment evidence lives
This page deliberately covers epidemiology only. One medication is FDA-approved for control of clinical signs associated with CCD (selegiline, NADA 141-080); controlled trials also exist for a therapeutic diet and for supplement formulations, alongside smaller uncontrolled reports. We review that evidence – designs, sizes, limitations, and what each study can and cannot show – in our supplements evidence guide and medication guide.
Citing this page? Copy the line below – and cite the primary study alongside us whenever possible; every statistic above links to it.
Dog Dementia Statistics 2026: Prevalence, Diagnosis Rates, and Risk Factors. Dr. Fossum’s Pet Care. https://drfossums.com/dog-dementia/statistics/. Updated September 2026.
Methodology and update policy
Scope rule: this page reports epidemiology – prevalence, diagnosis rates, risk-factor associations, practice patterns, and caregiver findings. It does not report intervention efficacy; that evidence is reviewed on the linked guides with full study context. Every statistic is traced to the entity that produced it and linked directly; no number is quoted from another roundup. Statistics were last re-verified against their primary sources on September 13, 2026. Corrections are preserved in the changelog rather than silently overwritten; statistics that fail re-verification are removed. A section reporting original aggregate data from owner-completed cognitive screenings on this site is planned once the sample is large and stable enough to report responsibly.
Changelog
Sep 13, 2026 – Published. Pre-publication corrections after independent adversarial review: underdiagnosis stated as two separate population rates; superlatives removed; survival, body-size, and activity findings qualified to match study designs; scope limited to epidemiology (intervention evidence lives on the linked guides).
References and further reading
- Salvin HE, McGreevy PD, Sachdev PS, Valenzuela MJ. Under diagnosis of canine cognitive dysfunction: a cross-sectional survey of older companion dogs. Vet J. 2010;184(3):277-281. PMID 20005753
- Neilson JC, Hart BL, Cliff KD, Ruehl WW. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. JAVMA. 2001;218(11):1787-1791. PMID 11394831
- Yarborough S, Fitzpatrick A, Schwartz SM; Dog Aging Project Consortium. Evaluation of cognitive function in the Dog Aging Project: associations with baseline canine characteristics. Sci Rep. 2022;12:13316. PMID 36008509 (author correction: PMID 37253931)
- Simon KE, Gruen ME, Olby NJ. Current practices for diagnosis and management of Canine Cognitive Dysfunction Syndrome in the United States. Front Vet Sci. 2025;12:1685430. PMID 41234399
- Olby NJ, et al. The Canine Cognitive Dysfunction Syndrome Working Group guidelines for diagnosis and monitoring of canine cognitive dysfunction syndrome. JAVMA. Online Dec 24, 2025; print Apr 2026. PMID 41442884
- Fast R, Schutt T, Toft N, Moller A, Berendt M. An observational study with long-term follow-up of canine cognitive dysfunction: clinical characteristics, survival, and risk factors. J Vet Intern Med. 2013;27(4):822-829. PMID 23701137
- Simon KE, Russell K, Mondino A, et al. Quantifying placebo and trial participation effects on cognitive outcome measures in aging dogs. GeroScience. 2025;47(6):6909-6926. PMID 40789816
- Pavlin D, Hlebec V, Dousak M, Zakosek Pipan M. The hidden cost of caring: psychological burden among caregivers of dogs with cognitive dysfunction, cancer, and age-related decline. Vet J. 2026;315:106510. PMID 41314458
- Anipryl (selegiline hydrochloride) prescribing information. DailyMed, NADA 141-080. Label record
Frequently asked questions
What percentage of dogs get dementia?
There is no single number: a 2010 survey provisionally classified 14.2% of dogs over eight via owner questionnaire (Salvin 2010), while age-band data show owner-reported impairment reaching 28% at ages 11-12 and 68% at 15-16 (Neilson 2001). The spread reflects different measurements and age windows – see “Why do published estimates differ.”
Why do published prevalence estimates differ?
Because studies differ in what they measure (questionnaire classification vs reported diagnosis), how old their dogs are, and how they sample. A screening questionnaire will always find more provisional cases than the count of formal diagnoses.
Is dog dementia underdiagnosed?
The benchmark survey found 14.2% of dogs provisionally classified with CCD while 1.9% had a reported veterinary diagnosis – a gap its authors describe as underdiagnosis (Salvin 2010). A 2025 US survey adds context: most veterinarians cite missing guidelines and knowledge gaps as obstacles (Simon 2025).
Do dogs die from dementia?
One observational study of 94 dogs did not detect a negative association between CCD and survival, and its authors concluded supported dogs “seem to have a good chance of living a full lifespan” (Fast 2013). That is a population-level finding, not an individual prognosis – your veterinarian’s assessment of your dog is the number that counts.
This guide is educational and is not a substitute for veterinary diagnosis or care. If you are worried about your dog, talk to your veterinarian.